I'm not sure why you'd be back in again now. For a start Instos & Pharma have had the most recent results since March and the other trial data for years yet they haven't acted in any significant manner to date. Maybe the Instos & Pharma aren't interested because NEU have been all over the place chasing multiple targets instead of focusing their limited funds on one indication or possibly because there's still a very long way to go in the area of neurodevelopmental disorders and in particular the IGF-1 pathway. Therefore they are directing their interests into the pipeline of the hot in demand neurodegenerative disease indications such as Alzheimers & Parkinson's etc. (which have the most partnering activity).
I'm not sure why you'd be back in again now. For a start Instos...
-
- There are more pages in this discussion • 115 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.27 |
Change
0.650(3.15%) |
Mkt cap ! $2.718B | |||
| Open | High | Low | Value | Volume |
| $20.84 | $21.56 | $20.76 | $7.760M | 364.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1378 | $21.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.29 | 218 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |